Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/14/2026

ASA Physical Status Classification System and Clinical Implications

System Overview

  • The American Society of Anesthesiologists (ASA) Physical Status Classification is a six‑tier system (ASA I–VI) that categorizes patients by pre‑operative health status, with an optional “E” suffix for emergency procedures. 1

Classification Definitions

ASA I – Normal Healthy Patient

  • Represents a healthy, nonsmoking adult with minimal or no alcohol consumption and no identifiable organic, physiological, biochemical, or psychiatric disturbance. [1][2]

ASA II – Mild Systemic Disease

  • Describes patients with mild systemic conditions that do not limit daily activities (e.g., current smoking, social alcohol use, pregnancy, obesity with BMI 30–40 kg/m², well‑controlled diabetes or hypertension, mild respiratory disease). 1
  • The presence of mild systemic disease without functional limitation is confirmed by expert consensus. [3][4]

ASA III – Severe Systemic Disease

  • Applies to patients with one or more moderate‑to‑severe diseases that cause substantive functional limitations (e.g., poorly controlled diabetes or hypertension, chronic obstructive pulmonary disease, morbid obesity with BMI ≥ 40 kg/m², active hepatitis, alcohol dependence, implanted cardiac pacemaker, moderate reduction in ejection fraction, end‑stage renal disease on regular dialysis, or a remote history (> 3 months) of myocardial infarction, cerebrovascular accident, transient ischemic attack, or coronary artery disease with stents). 1
  • These patients exhibit moderate or severe systemic disease that limits their activities. [3][4]

ASA IV – Severe Life‑Threatening Systemic Disease

  • Assigned to patients with severe systemic disease that poses a constant threat to life (e.g., recent (< 3 months) myocardial infarction, cerebrovascular accident, transient ischemic attack, or coronary artery disease with stents; ongoing cardiac ischemia or severe valvular dysfunction; severe reduction in ejection fraction; sepsis; disseminated intravascular coagulation; acute respiratory distress syndrome; or end‑stage renal disease not on scheduled dialysis). 1
  • Includes severe congestive heart failure or end‑stage renal failure. [3][4]

ASA V – Moribund Patient

  • Indicates a patient who is unlikely to survive without the operative intervention (e.g., ruptured abdominal or thoracic aneurysm, massive trauma, intracranial hemorrhage with mass effect, ischemic bowel in the setting of significant cardiac disease, or multiple organ/system dysfunction). 1
  • These patients have a substantial risk of death within 24 hours, irrespective of whether surgery is performed. [3][4]

ASA VI – Brain Death

  • Designates a brain‑dead individual from whom organs are being harvested for transplantation. 1

Emergency Designation

  • The “E” suffix denotes an emergency operation in which any delay would markedly increase the threat to the patient’s life or a body part; it may be appended to any ASA class from I to V. [1][3]4

Clinical Application

Sedation and Procedural Planning

  • Patients classified as ASA I–III are considered appropriate candidates for sedation administered by the proceduralist (e.g., endoscopist) without mandatory anesthesia specialist involvement. [3][4]
  • Patients classified as ASA IV–V should receive sedation under the supervision or assistance of an anesthesia specialist to ensure safety. [3][4]

Pre‑Procedural Assessment and Monitoring

  • The ASA classification guides the depth of pre‑procedural assessment and determines the level of intra‑operative monitoring required for each patient. [1][5]

ASA Physical Status Classification – Evidence‑Based Definitions and Clinical Implications

ASA Classification Definitions (American Society of Anesthesiologists)

  • ASA I – Normal healthy patient: A healthy, nonsmoking individual with no or minimal alcohol use and no organic, physiologic, biochemical, or psychiatric disturbance. 6
  • ASA II – Mild systemic disease: Presence of mild diseases that do not cause substantive functional limitations (e.g., current smoking, social alcohol use, pregnancy, obesity with BMI 30–40 kg/m², well‑controlled diabetes or hypertension, mild lung disease). 6
  • ASA III – Severe systemic disease: One or more moderate‑to‑severe diseases that cause substantive functional limitations (e.g., poorly controlled diabetes or hypertension, COPD, morbid obesity with BMI ≥ 40 kg/m², active hepatitis, alcohol dependence, implanted pacemaker, moderate reduction of ejection fraction, end‑stage renal disease on regular dialysis, remote (>3 months) history of myocardial infarction, stroke, TIA, or coronary artery disease with stents). 6
  • ASA IV – Severe life‑threatening disease: Severe systemic disease that poses a constant threat to life (e.g., recent (<3 months) myocardial infarction, stroke, TIA, or coronary artery disease with stents; ongoing cardiac ischemia or severe valve dysfunction; severe reduction of ejection fraction; sepsis; disseminated intravascular coagulation; acute respiratory distress syndrome; end‑stage renal disease not on scheduled dialysis). 6
  • ASA V – Moribund patient: Not expected to survive without the operative intervention (e.g., ruptured abdominal or thoracic aneurysm, massive trauma, intracranial hemorrhage with mass effect, ischemic bowel with significant cardiac pathology, multiple organ/system dysfunction). 6
  • ASA VI – Brain‑dead patient: Declared brain‑dead individual whose organs are being harvested for transplantation. 6

Emergency Surgery Designation (American Society of Anesthesiologists)

  • The “E” suffix denotes emergency surgery—situations in which delay would significantly increase the threat to life or to a body part—and may be appended to any ASA class I–V. 6

Sedation Guidelines for Proceduralists (Gastroenterology Society)

  • ASA I–III patients are appropriate candidates for moderate sedation administered by the proceduralist (e.g., gastroenterologist during endoscopy) without mandatory involvement of an anesthesia specialist. 7

Postoperative Pulmonary Complication Risk (American Society of Anesthesiologists)

  • Patients classified as ASA ≥ II have a markedly increased risk of postoperative pulmonary complications, with an odds ratio of 4.87 (95 % CI 3.34–7.10) compared with ASA <I.** 8
  • Patients classified as ASA ≥ III also show elevated risk, with an odds ratio of 2.25 (95 % CI 1.73–3.76) versus ASA <I.** 8

Perioperative Mortality and Complication Risk by ASA Physical Status and Cardiac Factors

ASA Grade–Associated Post‑operative Delirium

  • In patients classified as ASA II, the incidence of postoperative delirium is approximately 10 %. 9
  • In ASA III patients, postoperative delirium rises to about 20 %. 9
  • ASA IV patients experience postoperative delirium in roughly 39 % of cases, reflecting a markedly higher risk of severe peri‑operative complications. 9

Mortality Rates for Aortic Valve Replacement (AVR) Procedures

  • Isolated AVR in the general adult population carries an in‑hospital mortality of 3–4 %. 10
  • AVR combined with coronary‑artery bypass grafting (CABG) shows a higher mortality of 5.5–6.8 %. 10
  • Among Medicare beneficiaries > 65 years undergoing AVR, overall in‑hospital mortality is 8.8 %; mortality is 13 % in low‑volume centers versus 6 % in high‑volume centers, underscoring the impact of institutional experience. 10

Severe Aortic Stenosis (AS) and Non‑cardiac Surgery

  • Patients with severe AS who undergo non‑cardiac surgery have a 30‑day mortality of 2.1 %, compared with 1.0 % in matched patients without AS. [11][12]
  • Historical data using the Original Cardiac Risk Index indicate that severe AS was associated with a 13 % peri‑operative mortality, versus 1.6 % in patients without AS. [11][12]

Age, Functional Capacity, and ASA Grade

  • Adults aged ≥ 65 years with an ASA classification of ≥ III demonstrate a significantly higher peri‑operative mortality compared with younger or lower‑ASA cohorts. 13
  • Poor functional capacity (e.g., inability to achieve ≥ 4 METs or climb two flights of stairs) independently predicts increased peri‑operative mortality. 13

Influence of Surgical Volume and Center Experience

  • Low‑volume surgical centers exhibit a 33 % higher mortality for AVR procedures compared with high‑volume centers, reflecting the importance of procedural volume on outcomes. 10
  • For elderly patients undergoing AVR, mortality is 13 % in low‑volume centers versus 6 % in high‑volume centers, reinforcing the benefit of referral to experienced institutions. 10

ASA Physical Status Classification – Definitions, Emergency Designation, and Clinical Application

Classification Definitions

  • The American Society of Anesthesiologists (ASA) Physical Status Classification is a six‑tier system (ASA I–VI) that categorizes patients by pre‑operative health status, with an optional “E” suffix for emergency procedures. 14
  • ASA I – Normal healthy patient: a healthy individual with no organic, physiologic, biochemical, or psychiatric disturbance; excludes the very young and very old; demonstrates good exercise tolerance. Evidence: ASA guideline description. 14
  • ASA II – Mild systemic disease: systemic disease that does not limit daily activities or cause functional limitations. Representative conditions include well‑controlled hypertension or diabetes, current cigarette smoking without chronic obstructive pulmonary disease, and pregnancy. Evidence: ASA guideline description (multiple sources). [14][15]
  • ASA III – Severe systemic disease: moderate‑to‑severe systemic disease causing substantive functional limitations, but without immediate danger of death. Representative conditions include poorly controlled hypertension or diabetes, stable angina or prior myocardial infarction (> 3 months), controlled congestive heart failure, chronic renal failure or end‑stage renal disease on regular dialysis, and COPD with intermittent bronchospastic symptoms. Evidence: ASA guideline description. [14][15]
  • ASA IV – Severe life‑threatening systemic disease: severe disease that is poorly controlled or at end‑stage, posing a constant threat to life. Representative conditions include unstable angina or ongoing cardiac ischemia, symptomatic COPD or congestive heart failure, and hepatorenal failure. Evidence: ASA guideline description. [14][15]
  • ASA V – Moribund patient: patient not expected to survive 24 hours without surgery, with imminent risk of death. Representative conditions include multiorgan failure or sepsis syndrome with hemodynamic instability and poorly controlled coagulopathy or hypothermia. Evidence: ASA guideline description. [14][15]
  • ASA VI – Brain‑dead patient: declared brain‑dead patient whose organs are being removed for donation. Evidence: ASA guideline description. [14][15]

Emergency Designation

  • The “E” suffix denotes an emergency surgery in which any delay would markedly increase the threat to the patient’s life or a body part; it can be appended to any ASA class I–V (e.g., ASA III‑E). 15

Clinical Application for Sedation and Procedural Care

  • ASA I–III patients are appropriate candidates for moderate sedation administered by the proceduralist (e.g., gastroenterologist during endoscopy) without mandatory involvement of an anesthesia specialist. [15][16]
  • ASA IV and V patients should receive sedation under the supervision or assistance of an anesthesia specialist. 15
  • Additional situations that warrant anesthesia‑specialist involvement (regardless of ASA class) include:
    • Emergency endoscopic procedures,
    • Complex procedures such as ERCP or endoscopic ultrasound,
    • History of adverse reaction to sedation,
    • Alcohol or substance‑abuse history,
    • Inadequate response to moderate sedation. Evidence: ASA guideline recommendation. 15

Pre‑Procedure Fasting Requirements

  • A minimum of 2 hours fasting for clear liquids and 6 hours for light meals is required before sedation. [14][16]
  • These fasting intervals should be lengthened in patients with gastric‑emptying abnormalities. [14][16]

ASA Classification Criteria Based on Cited Evidence

End‑Organ Damage and Hypertension (European Heart Journal 2014) 17

Prediabetes and Metabolic Disturbance (Circulation 2019) 18

REFERENCES